FBXL18 was positively associated with TNM stage, histological grade, tumor size, vascular thrombosis, and metastasis in HCC patients (Fig. 1E, F and Table 1), indicating that FBXL18 expression is positively correlated with poor prognosis in HCC patients. The gene discussed is FBXL18; the disease is hepatocellular carcinoma.